D
Cartesian Therapeutics, Inc. RNAC
$10.78 -$0.47-4.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 84.21% 84.97% 64.76% -16,364.63% --
Total Depreciation and Amortization 199.64% 159.02% 36.54% -47.06% --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -111.65% -94.17% -64.12% 5,708.80% --
Change in Net Operating Assets 156.77% 7.09% -216.50% 69.36% --
Cash from Operations 46.01% 47.07% 53.73% 30.69% --
Capital Expenditure -369.33% -1,310.91% -4,314.08% -609.06% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -100.00% --
Cash from Investing -337.30% -256.64% -125.26% -114.26% --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- 100.00% --
Issuance of Common Stock 3,785.28% 3,936.17% 55,525.11% 222.69% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -100.00% -100.00% 97.53% -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -34.53% -34.12% 98.93% -5,508.18% --
Cash from Financing 261.59% 294.70% 1,381.31% 1,415.77% --
Foreign Exchange rate Adjustments 180.00% 143.24% 60.38% 120.41% --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 380.23% 440.11% 557.11% 531.10% --